Healthcare >> CEO Interviews >> January 10, 2001
DR. Jim W. Young became CEO of Sunesis in May 2000. Previously, Dr.
Young served as Group Vice President of ALZA Corporation's Technologies
division. At ALZA, he was responsible for R&D programs that led to
several successful in-house and client-sponsored new drug applications
with the FDA. Prior to this, Dr. Young was President of the
pharmaceuticals division at Affymax, NV and senior Vice President and
General Manager of the pharmaceuticals division of Sepracor Inc. Dr.
Young also held a number of positions during 17 years at Zoecon
Corporation/Sandoz Crop Protection Corporation, most recently as vice
president of research. Dr. Young earned his PhD degree in Organic
Chemistry from Cornell University. He received his Bachelor of Science
degree in Chemistry from Fordham University in New York. Profile
Sunesis?
Dr. Young: Sunesis was founded in June 1998 to accelerate the discovery
of small molecule drugs against
